Why Patients Are Falling Through the Cracks
Patients discharged from emergency rooms often receive paper instructions that never reach their next caregiver, creating dangerous gaps in care. While health‑record digitization and nationwide health‑information exchanges have moved millions of records, the data remains passive, leading to missed follow‑ups, medication errors, and costly readmissions. The article cites $340 billion in wasted resources and 1.5 million medication‑related injuries each year as evidence of systemic failure. It argues that real‑time alerts and actionable data, not just connectivity, are essential to fix the transition problem.
Reimagining Medical Devices in the AI Era: The 3 Structural Shifts Driving Venture-Scale Growth
Aegis Ventures released a whitepaper that spotlights three AI‑driven structural shifts reshaping the medical‑device sector. Historically, medtech has captured only 2‑3% of U.S. healthcare venture capital despite a $200 billion annual market, reflecting long development cycles and limited exit paths. The...
More Than 5 Million US Adults Could Benefit From Lp(a)-Targeted Therapies
New analysis presented at ACC.26 estimates over 5.3 million U.S. adults with ASCVD and Lp(a) ≥ 70 mg/dL could qualify for emerging Lp(a)-lowering therapies. Modeling suggests a 10‑30% relative risk reduction could prevent 123,000‑368,000 recurrent cardiovascular events over five years, roughly 25,000‑74,000 per year....
FDA's Unreleased Covid Vaccine Deaths Report Is Published by Lawmaker
A Republican lawmaker released an FDA-commissioned analysis examining alleged pediatric deaths linked to COVID‑19 vaccines, a report the agency failed to publish by its own deadline. The study, led by former FDA officials, concluded there is no statistically significant rise...
How Scientists Developed a Hantavirus PCR Test in a Weekend
Scientists at Nebraska's Public Health Laboratory rapidly engineered a polymerase chain reaction (PCR) test for Andes hantavirus over the May 9‑10 weekend. The assay enables detection of viral RNA in blood, allowing identification of infections before symptoms emerge, unlike the CDC’s...
What Medicare Advantage Plans Must Do to Prepare for 2026 Audits
CMS is tightening Medicare Advantage risk‑adjustment oversight in 2026, moving to full V28 payment and launching a series of RADV audits that begin with PY 2018 findings. The agency has published a detailed audit calendar covering PY 2020, 2021, 2023...
Inflammation Common in HF, No Matter the Ejection Fraction: POSEIDON
The POSEIDON international registry of nearly 19,000 atherosclerotic patients found that 38‑39% of those with symptomatic heart failure have high‑sensitivity C‑reactive protein (hs‑CRP) ≥2 mg/L, a prevalence that is virtually identical across HFrEF, HFmrEF and HFpEF. Elevated hs‑CRP correlated with a...
Survival After SARD-ILD Exacerbation Differs by Race/Ethnicity
A retrospective review of 46 patients hospitalized for acute exacerbations of systemic autoimmune‑related interstitial lung disease (SARD‑ILD) found marked racial disparities in long‑term outcomes. Black patients experienced the highest 1‑year mortality at 55%, while white patients had the lowest at...
Pegtarazimod Improves Oxygen Use in Acute COPD Exacerbation
Phase 2a data presented at the American Thoracic Society meeting show that pegtarazimod, an anti‑inflammatory peptide, improved oxygen utilization and lung‑function metrics in hospitalized adults with acute COPD exacerbations. In a double‑blind trial of 21 patients, the 10‑person pegtarazimod arm reduced...
Why Clinician-Led AI Strategies Are Gaining Momentum in Healthcare
Presbyterian Healthcare Services has placed a practicing nurse practitioner, Lori Walker, as its chief medical information officer to lead its AI transformation, emphasizing a clinician‑led strategy. Walker’s frontline experience lets her evaluate AI tools against real workflow constraints, fostering trust...
Opioid Use Duration Should Be Reduced After Ocular Surgery: Anton Kolomeyer, MD, PhD
A 2019 JAMA Ophthalmology study led by Dr. Anton Kolomeyer found that patients undergoing incisional eye surgery filled opioid prescriptions more frequently in 2014‑2016 than in 2000‑2001. The analysis showed higher prescribing rates for trauma, pediatric, and extensive procedures such...
Supreme Court Declines to Hear Drugmakers' Challenge to Price Negotiations
The U.S. Supreme Court declined to hear appeals from six major drug manufacturers seeking to block the Medicare Drug Price Negotiation Program. The decision leaves lower‑court rulings that uphold the program intact, allowing the government to continue negotiating prices for...
MSD's Sac-TMT Delivers in First Phase 3 Readout
Merck (MSD) reported that its TROP2‑targeting antibody‑drug conjugate sacituzumab tirumotecan (sac‑TMT), licensed from China’s Kelun‑Biotech, improved progression‑free and overall survival in a phase 3 trial for advanced or recurrent endometrial cancer. The TroFuse‑005 readout marks the first pivotal data for sac‑TMT...
How a Funding Pause Derailed an Artificial Heart for Babies
James Antaki, a biomedical engineer at Cornell, was on the brink of delivering a battery‑size artificial heart for infants when the Trump administration froze over $1 billion in federal research funding, forcing his lab to shut down and staff to be...
FDA Clears Next-Gen Contrast Management System for the Cath Lab
Acist Medical Systems, a Bracco subsidiary, received FDA clearance for its Acist Pro Diagnostic System, a next‑generation contrast management platform for cardiac catheterization labs. The system, already launched in Japan and Europe, offers real‑time contrast tracking, customizable presets, and on‑screen...
Children’s Mental Health Visits Have Shot Up, Research Shows
A new JAMA Network Open study of 1.8 million Massachusetts children shows pediatric mental‑health visits climbed from 5.7% of all visits in 2014 to 9.7% in 2023. Anxiety appointments surged more than 250%, rising from 1.7% to 6.1% of visits. Smaller...
Verbal Beginnings to Expand in Maryland with New Early Intervention Autism Center in Lanham, MD
Verbal Beginnings is opening its ninth Early Intervention Autism Center in Lanham, Maryland, slated for August 2026. The facility will serve children ages 1‑5 across Prince George’s County, offering center‑based Applied Behavior Analysis alongside Speech‑Language Pathology, Occupational Therapy, and parent‑training...
Høeg Fired in Latest FDA Shakeup; 20 People Die After Taking Amgen Drug
The FDA announced a leadership overhaul, firing acting CDER director Tracy Beth Høeg and installing Michael Davis as acting head, while Karim Mikhail now leads CBER. In Japan, 20 patients died after receiving Amgen’s rare‑disease drug Tavneos, prompting a warning and an existing U.S....
Merck's ADC Sac-TMT Gets Its First Global Phase 3 Win Ahead of Schedule
Merck and China‑based Kelun‑Biotech announced that their experimental antibody‑drug conjugate sac‑TMT achieved its primary endpoint in a global Phase 3 trial, completing ahead of schedule. The study enrolled roughly 650 patients with advanced solid tumours across 12 countries and demonstrated a...
Our AI Wearables Are “Changing the Game” For Disabled People
Meta unveiled a suite of new AI‑powered features for its Ray‑Ban and Oakley smart glasses, aimed at expanding independence for people with disabilities. The rollout adds hands‑free group calling with Be My Eyes, voice‑only call controls, one‑touch shortcuts, and real‑time...
Sutter Health Strengthens Maternal Care Through Innovation and Connection
Sutter Health launched a systemwide maternal‑care initiative that aligns evidence‑based protocols, data dashboards, and multidisciplinary collaboration across its 16 labor‑and‑delivery sites. By expanding certified nurse‑midwife access, integrating doula support, and scaling group prenatal care, the health system increased CNM‑delivered births...
Sotatercept Reduced Morbidity in CTD-PAH Analysis: Rogerio Souza, MD, PhD
A pooled analysis of the phase‑3 STELLAR, ZENITH and HYPERION trials shows that sotatercept significantly lowers the risk of first major morbidity or mortality events in patients with connective tissue disease‑associated pulmonary arterial hypertension (CTD‑PAH). The benefit persisted despite most...
FDA Approves Baxdrostat for Inadequately Controlled Hypertension
AstraZeneca’s Baxdrostat (Baxfendy) received FDA approval as the first aldosterone synthase inhibitor for hypertension in the United States. The drug is indicated for patients whose blood pressure remains uncontrolled despite taking at least two other antihypertensive agents. Phase III trials (BaxHTN...
Why Real-World Evidence Is Becoming the Missing Link Between Innovation and Patient Care in Oncology
Oncology’s rapid innovation—targeted therapies, immunotherapies, and precision medicine—outpaces the ability of traditional clinical trials to predict real‑world performance. Real‑world evidence (RWE) bridges this gap by using longitudinal, clinically rich data to show how treatments work across diverse patient populations and...
Behavioral Science: The Missing Link in Remote Monitoring
Remote patient monitoring (RPM) programs often falter not because the technology fails, but because they ignore how patients actually behave. Behavioral science offers proven design tactics—smart defaults, loss framing, habit linking, adaptive messaging, and temporal landmarks—that can dramatically lift engagement....
Healthcare Reimbursement: Succeeding Under Value-Based and FFS Payment
Healthcare reimbursement models—fee‑for‑service, DRGs, capitation, and value‑based care—shape hospital cash flow and risk exposure. Providers must master each model’s incentive structure and execute a five‑step claims process, from documentation to patient billing. Errors in coding, claim submission, or payer adjudication...
What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape
PSMA‑targeted radioligand therapy, exemplified by lutetium‑177 vipivotide tetraxetan (Pluvicto), is now a standard option for metastatic castration‑resistant prostate cancer. However, response durability is limited, with fewer than half of patients achieving meaningful benefit and most eventually progressing. The authors highlight...
Atropos Health and Guidehouse Launch Point-of-Care Clinical Decision Support Solution
Atropos Health and consulting firm Guidehouse have launched a joint clinical decision support (CDS) platform that embeds predictive AI models directly into electronic health records. The solution uses aggregated claims and EHR data to stratify patients and deliver real‑time alerts...
Pittsburgh Researchers Develop Shelf-Stable Artificial Platelets to Stop Severe Bleeding
Researchers at the University of Pittsburgh, in partnership with Case Western Reserve and Haima Therapeutics, have created SynthoPlate, a freeze‑dried artificial platelet that reconstitutes with water to form a clotting agent. The quarter‑sized vial remains stable at room temperature for...
The Growing Need for Acupuncturists in Modern U.S. Healthcare
Chronic pain management in the U.S. is shifting toward non‑pharmacologic solutions, and acupuncture is emerging as a core component of integrative pain programs across hospitals and primary‑care networks. The American College of Physicians’ 2017 guideline now lists acupuncture as a...
The Ebola Emergency Shines a Light on the Urgent Need for New Vaccines
The Democratic Republic of Congo and Uganda are facing a Bundibugyo Ebola outbreak, with the U.S. CDC reporting 336 suspected cases and 88 deaths as of 17 May. The WHO declared a public‑health emergency of international concern, but its response is...
Healthcare Doesn’t Need More Companies Managing Unnecessary Costs – It Needs a System Designed to Eliminate Them
The U.S. spends roughly $5.3 trillion on healthcare, with about 20% tied up in administrative waste. Most cost‑containment firms still operate on a percent‑of‑savings model, taking 15‑30% of negotiated reductions and rewarding higher bills. Navin Nagiah argues that this misaligned incentive...
How Advanced Analytics Partnerships Enhance the Biopharma Value Chain
Strategic biopharma alliances are increasingly embedding multimodal AI across the entire drug‑development pipeline. Partnerships leverage foundation models to sharpen biomarker discovery and patient selection for complex modalities such as antibody‑drug conjugates. Large‑scale genomic and clinical datasets enable virtual cell modeling...
Do Wall Street Analysts Like Welltower Stock?
Welltower Inc., a $150.9 billion healthcare REIT, posted a 45.5% stock surge over the past year, outpacing the S&P 500 and its real‑estate peers. First‑quarter 2026 results showed normalized FFO of $1.47 per share, a 23% year‑over‑year rise, and revenue of $3.35 billion,...
Millions Impacted Across Several US Healthcare Data Breaches
Several U.S. healthcare providers disclosed massive data breaches that together affect millions of patients. The New York City Health and Hospitals Corporation reported a breach compromising 1.8 million records, while Erie Family Health Centers, Florida Physician Specialists, Coastal Carolina Health Care,...
Data Interoperability in Healthcare Apps: Why It Matters
Healthcare apps now span telehealth, remote monitoring, imaging and AI, but fragmented data hampers their value. Interoperability lets disparate systems exchange patient information securely, eliminating manual copying and duplicate entry. Standards such as HL7, FHIR and DICOM enable these connections,...
Merck Eyes $6 Billion in Seven-Part Bond Sale for Terns Deal
Merck & Co. is planning a $6 billion investment‑grade bond issuance to finance its purchase of Terns Pharmaceuticals. The debt will be offered in up to seven separate tranches, with the longest being a 30‑year note. The senior tranche is expected...
How Peer-Driven Feedback Is Reshaping Healthcare Technology Purchasing Decisions
Healthcare buyers are moving away from vendor‑centric demos toward peer‑driven feedback when evaluating digital health platforms. Executives now prioritize real‑world implementation insights, workflow integration, and user experience over feature lists and AI hype. This shift comes as hospitals grapple with...
Rural Hospital Closures Disrupt Care Access for Injured Workers but Don’t Worsen Claim Outcomes
A Workers Compensation Research Institute study of more than 12 million claims across 29 states found that rural hospital closures cut same‑day emergency care use by 3.6 percentage points and added an average of 10.5 miles to travel distance. The impact was...
Novartis Reveals More Data Behind Pluvicto Expansion Bid
Novartas reported new PSMAddition trial data showing that adding its radioligand therapy Pluvicto to standard hormonal treatment cuts PSA progression by 58% in hormone‑sensitive metastatic prostate cancer. Deep PSA reductions below 0.2 ng/mL were achieved by 87.4% of patients versus 74.9%...
Amgen’s Rare Disease Drug Tavneos Tied to 20 Deaths in Japan
Amgen’s rare‑disease drug Tavneos has been linked to 20 deaths among roughly 8,500 Japanese patients, primarily due to vanishing bile duct syndrome, a severe form of drug‑induced liver injury. The Japanese distributor Kissei Pharmaceutical has warned doctors against initiating new...
10 Key Lessons in 'the Shift From CoPilots to Agents in Healthcare'
Healthcare is moving from reactive AI copilots to autonomous agents that can execute multi‑step clinical workflows with minimal human input. Global AI spending is projected to hit $2.52 trillion in 2026, while AI firms secured $242 billion in Q1 2026, fueling rapid adoption...
Harbour Posts Preclinical Data on Would-Be Rival to Eli Lilly’s $1.9B Obesity Bet
Harbour BioMed released preclinical data on LET003, an ACVR2A/2B‑targeting monoclonal antibody created with its AI‑enabled Hu‑mAtrIx platform. In mouse and monkey studies the molecule cleared more slowly than comparators and drove a 13.5% increase in lean mass versus a rival...
Reminder Texts Help Radiology Department Reduce Nuclear Medicine Appointment Cancelations
Automated reminder texts introduced by the Mayo Clinic in Jacksonville have cut cancellations for nuclear medicine exams. In a study published in JACR, opening the messages lowered stress‑test cancellations to 3.21% versus 5.91% overall, and FDG PET cancellations fell to...
The Next AI Use Case in Radiology Isn’t Diagnosis. It’s Patient Understanding
Peter Nemeth argues that the first scalable AI use case in radiology is not autonomous diagnosis but patient‑focused explanation of imaging results. The 21st Century Cures Act now forces health portals to release reports instantly, leaving most patients confused by...
Sandoz Reports the EC Approval of Bysumlog and Dazparda (Biosimilars, Humalog and NovoRapid)
The European Commission has granted approval for Sandoz's biosimilar insulin pens Bysumlog (insulin lispro) and Dazparda (insulin aspart). Both products are authorized as prefilled pens for diabetes treatment in adults, children and patients as young as one year, demonstrating efficacy...
Hospital Cyber Attacks Are Increasingly Hitting Patient Care
European hospitals are facing a dramatic shift in cyber risk, with 82 % rating the threat as extreme and 74 % expecting a major incident this year. Attackers now target authentication, clinical workflows and digital patient‑care pathways, turning cybersecurity into a direct...
BIO Supports and Seeks Refinements to FDA’s Plausible Mechanism Framework
The FDA has issued draft guidance introducing a Plausible Mechanism Framework to evaluate safety and efficacy of individualized, disease‑targeted therapies when traditional trials are infeasible. The Biotechnology Innovation Organization (BIO) issued a supportive comment letter, praising the agency’s direction while...
We Need to Domesticate Africa’s Health Algorithm
The article argues that Africa must domesticate its health‑data AI ecosystem to capture economic and public‑health value. While the continent boasts some of the world’s most diverse and under‑represented health data, less than 1% of global data‑center capacity and 70‑90%...
Supercharging Immune Cells May Help Control HIV Long-Term
Scientists have repurposed CAR‑T cell therapy, originally used for cancer, to target HIV. In a small Phase 1 trial, two participants who received the engineered T cells remained off antiretroviral drugs with undetectable viral loads for nearly two years and one...